Financial Statements

Bayer Group Consolidated Statements of Financial Position

			[Table 21]
	June 30, 2009	June 30, 2010	Dec. 31, 2009
	€ million	€ million	€ million
Noncurrent assets
Goodwill	8,564	9,207	8,704
Other intangible assets	13,179	12,514	12,842
Property, plant and equipment	9,417	10,118	9,409
Investments accounted for using the equity method	415	398	395
Other financial assets	1,292	1,332	1,200
Other receivables	492	556	549
Deferred taxes	1,403	1,506	950
	34,762	35,631	34,049
Current assets
Inventories	6,312	6,743	6,091
Trade accounts receivable	6,785	7,603	6,106
Other financial assets	473	234	367
Other receivables	1,271	1,617	1,357
Claims for income tax refunds	255	296	347
Cash and cash equivalents	1,834	2,551	2,725
	16,930	19,044	16,993

Total assets	51,692	54,675	51,042

Equity
Capital stock of Bayer AG	2,117	2,117	2,117
Capital reserves of Bayer AG	6,167	6,167	6,167
Other reserves	10,167	10,659	10,613
Equity attributable to Bayer AG stockholders	18,451	18,943	18,897
Equity attributable to non-controlling interest	56	59	54
	18,507	19,002	18,951

Noncurrent liabilities
Provisions for pensions and other post-employment benefits	6,480	7,839	6,517
Other provisions	1,366	1,547	1,516
Financial liabilities	11,835	11,041	11,460
Other liabilities	444	524	415
Deferred taxes	3,568	2,895	3,210
	23,693	23,846	23,118
Current liabilities
Other provisions	3,568	3,956	3,089
Financial liabilities	2,304	2,788	1,489
Trade accounts payable	2,080	3,164	2,735
Income tax liabilities	71	48	93
Other liabilities	1,469	1,871	1,567
	9,492	11,827	8,973

Total equity and liabilities	51,692	54,675	51,042
2009 figures restated

http://www.stockholders-newsletter-q2-2010.bayer.com/en/financial-position.aspx

Copyright © Bayer AG